公司資料
Navidea 股價、新聞與催化劑
- 股票代碼:
- NAVB
- 交易所:
- AMEX
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for NAVB.
公司概覽
業務概覽
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches. Its story reflects the difficulty of sustaining a narrow clinical and commercial platform over time.
所在地與產業分類
Navidea is headquartered in the United States and listed on NYSE American. It sits in small-cap biotech and medical imaging-adjacent therapeutics.
商業模式特徵
The company depends on corporate restructuring, financing, and the ability to preserve value in a very narrow asset set. Investors historically watched regulatory developments and strategic shifts.
生技產業定位
Navidea occupies a legacy small-cap biotech niche. The stock has long been driven more by capital structure and survival than by broad commercial scale.
未來催化劑
- Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。